Specific Practice & Industry Groups Details:
Statement of Practice Summary:
Antitrust; Competition Law; Banking Law; Finance; Business and Tort Litigation - USA; Business Restructuring; Reorganization; Capital Markets; Corporate Criminal Investigations; Employee Benefits; Executive Compensation; Energy; Environmental Law; Health Law; Safety; Financial Institutions Litigation; Regulation; Global Disputes; Government Regulation; Health Care; Insurance Recovery; Intellectual Property; Issues; Appellate Practice; Labor and Employment; Life Sciences; Mergers and Acquisitions; Private Equity; Projects and Infrastructure; Real Estate; Securities Litigation; SEC Enforcement; Tax Law.
Documents by Lawyers at this office
The EPO's Undisclosed Disclaimers Trap-A Possible Way Out
Roland J. Graf,Sven Rihm,Bojan Savic, June 24, 2015
In its decision G 1/03, the jurisdiction of the European Patent Office ("EPO"), in particular the Enlarged Board of Appeal, has developed a possibility to disclaim novelty-destroying subject matter disclosed in prior art under Article 54(3) EPC, i.e., prior art filed before, but published...
FDA Finalizes Three Guidance Documents on Biosimilars
Edgar J. Asebey,Maureen Bennett,Christian B. Fulda,Colleen Heisey,Christopher M. Mikson, May 15, 2015
FDA recently finalized three draft guidance documents addressing scientific and regulatory issues associated with the development and licensure of biosimilars.
Languages: English, Farsi, French, German, Hungarian, Italian, Polish, Romanian and Spanish.